However, at lower antigen doses there was a requirement ... First, should syngeneic or allogeneic dendritic cells be used for tumor peptide presentation? Mature, syngeneic dendritic cells have ...

To be effective in cancer immunotherapy, tumor antigens must be efficiently ... mice injected with dendritic cells pulsed with the antigen peptide. In a related study, Laus et al.

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted ... enhances this process by using multiple tetanus toxin-derived B-cell epitopes (MTTEs) to ...